Sabra Healthcare REITSBRA
SBRA
About: Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
Employees: 48
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
283% more call options, than puts
Call options by funds: $6.99M | Put options by funds: $1.83M
89% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 28
33% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 4 (+1) [Q3]
30% more capital invested
Capital invested by funds: $3.34B [Q2] → $4.32B (+$987M) [Q3]
27% more repeat investments, than reductions
Existing positions increased: 138 | Existing positions reduced: 109
6% more funds holding
Funds holding: 349 [Q2] → 370 (+21) [Q3]
5.62% more ownership
Funds ownership: 93.62% [Q2] → 99.24% (+5.62%) [Q3]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$17
0%
upside
Avg. target
$19
12%
upside
High target
$20
18%
upside
3 analyst ratings
1 positive
33%
2 neutral
67%
0 negative
0%
Truist Securities Michael Lewis 64% 1-year accuracy 23 / 36 met price target | 0%upside $17 | Hold Downgraded | 17 Jan 2025 |
JMP Securities Aaron Hecht 54% 1-year accuracy 27 / 50 met price target | 18%upside $20 | Market Outperform Upgraded | 7 Jan 2025 |
Mizuho Vikram Malhotra 75% 1-year accuracy 6 / 8 met price target | 18%upside $20 | Neutral Downgraded | 5 Dec 2024 |
Financial journalist opinion
Based on 5 articles about SBRA published over the past 30 days
Positive
Barrons
5 days ago
Real Estate Stocks Bounce as Bond Yields Plunge. Consider These REITs.
The real estate sector has gotten cheap.
Positive
Seeking Alpha
2 weeks ago
Sabra Health Care REIT: Buy Into Future Demand For Skilled Nursing Facilities
Sabra Health Care REIT gets rated buy, agreeing with consensus, and driven heavily by macro-level demand forecasts for skilled nursing facilities. The stock is undervalued on forward P/FFO vs key peers, and is trading close to its moving average now. The firm has investment-grade ratings from Fitch and Moody's agencies.
Positive
Seeking Alpha
2 weeks ago
Sabra Health Care REIT: A High-Yielding Gift Just In Time For The New Year
With the FED's rate cut predictions for 2025, Sabra Health Care REIT offers a buying opportunity for long-term investors, especially retirees and income investors. Sabra's solid fundamentals, including improved occupancy rates and a safe 6% dividend yield, make it an attractive investment despite recent market sell-offs. The REIT's balance sheet has strengthened, with Moody's upgrading their outlook to positive, indicating potential for future investment opportunities and price appreciation.
Neutral
CNBC Television
3 weeks ago
Final Trades: Amazon, Sabra Health Care and the IEO
The Investment Committee give you their top stocks to watch for the second half.
Positive
Zacks Investment Research
3 weeks ago
Sabra (SBRA) Upgraded to Buy: Here's Why
Sabra (SBRA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Positive
Seeking Alpha
1 month ago
Sabra Health Care REIT: A Promising Value Play In Healthcare Real Estate
Sabra Health Care REIT offers a compelling investment opportunity with a reasonable valuation, trading at 13.6x 2024 FFO and 12.9x 2025 FFO. The company benefits from strong industry fundamentals, including an aging population and growing demand for senior living and healthcare facilities. Q3'24 results showed robust performance with occupancy gains and NOI growth, particularly in the SHOP portfolio, indicating effective operational leverage.
Neutral
Business Wire
2 months ago
Sabra Health Care REIT, Inc. to Attend Nareit's REITworld 2024 Annual Conference
TUSTIN, Calif.--(BUSINESS WIRE)-- #REITworld--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Senior Vice President of Finance, will attend Nareit's REITworld 2024 Annual Conference on November 19-20, 2024 at the Wynn Las Vegas in Las Vegas, Nevada. About Sabra Sabra Health C.
Neutral
Seeking Alpha
2 months ago
Sabra Health Care REIT, Inc. (SBRA) Q3 2024 Earnings Call Transcript
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q3 2024 Earnings Conference Call November 1, 2024 1:00 PM ET Company Participants Lukas Hartwich - Senior Vice President, Finance Rick Matros - Chief Executive Officer, President & Chair of the Board Talya Nevo-Hacohen - Chief Investment Officer, Treasurer & Executive Vice President Michael Costa - Chief Financial Officer Conference Call Participants Elmer Chang - Scotiabank John Kilichowski - Wells Fargo Austin Wurschmidt - KeyBanc Juan Sanabria - BMO Capital Michael Griffin - Citi Rich Anderson - Wedbush Alec Feygin - Baird Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank Operator Good day, everyone. My name is Adam, and I will be your conference operator today.
Positive
Zacks Investment Research
2 months ago
Sabra (SBRA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Positive
Zacks Investment Research
2 months ago
Sabra Healthcare (SBRA) Q3 FFO and Revenues Surpass Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to FFO of $0.34 per share a year ago.
Charts implemented using Lightweight Charts™